ALK mutations

Related by string. * alk . ALKS . alking . Alker . Alk : anaplastic lymphoma kinase ALK . ALK CoPilot . Alkermes ALKS . Alkermes NASDAQ ALKS . Inc. NYSE ALK . Group NYSE ALK . ALK Abello . Inc. NASDAQ ALKS / Mutations . Mutation : gene mutation . gene mutations . G#D mutation . genetic mutations identical . activating mutations . inherited mutations . spontaneous mutation . Bcr Abl T#I mutation * *

Related by context. All words. (Click for frequent words.) 69 somatic mutations 69 adenocarcinomas 69 Immunohistochemical analysis 69 hamartomas 68 virulence genes 68 PIK3CA 68 miRNA expression 68 ependymomas 67 epithelial tumors 67 MAPK pathway 67 HbF 67 chromosomal rearrangement 67 serous ovarian cancer 67 missense mutations 67 methylated DNA 67 PTPN# 67 sCJD 66 germline mutations 66 promoter methylation 66 molecular abnormalities 66 L. pneumophila 66 PARP inhibition 66 p# mutations 66 sarcosine 65 splice variants 65 serine protease 65 gene rearrangements 65 myeloproliferative diseases 65 tumorigenicity 65 GPx 65 etiologic agent 65 breast cancer subtypes 65 molecular biomarkers 65 DNA methylation patterns 65 PrPSc 65 FGFR3 65 sequence homology 65 mtDNA mutations 65 glycosylated 65 causal variants 65 non coding RNA 65 qRT PCR 65 tumor subtypes 65 orthologs 64 renal cell carcinomas 64 N. gonorrhoeae 64 genomic alterations 64 lobular carcinoma 64 tyrosine phosphorylation 64 miRNA genes 64 epigenetic modification 64 aneuploidies 64 EGF receptors 64 squamous cell lung cancer 64 KIAA# 64 c KIT 64 gene locus 64 GISTs 64 transgene expression 64 M. pneumoniae 64 Clusterin 64 precursor lesions 64 mutational analysis 64 serum antibodies 64 Nedd4 64 gene amplification 64 microdeletions 64 N glycan 64 ERBB2 64 metastatic lesions 64 mucinous 64 FGFR2 64 ZNF# 64 inherited mutations 64 p# mutation 64 idiopathic myelofibrosis 64 sporadic ALS 64 HDACi 64 uPAR 64 KLF4 64 K ras mutations 64 childhood leukemias 64 E. faecalis 64 isotypes 64 TP# gene 64 LRP5 64 HLA alleles 64 proteolytic cleavage 64 monogenic 64 BRAF gene 64 LRAT 63 isoenzymes 63 primary cilia 63 TMPRSS2 ERG fusion 63 carcinoid 63 lymphatic tissue 63 alternatively spliced 63 colorectal carcinoma 63 ADAMTS# 63 benign neoplasms 63 differentially expressed genes 63 carcinoids 63 microRNA expression 63 myelofibrosis polycythemia vera 63 MGUS 63 coding genes 63 chromosome aberrations 63 Chlamydia trachomatis 63 E1A 63 A3 adenosine receptor 63 recombinants 63 IgG4 63 LRP6 63 TLE3 63 prognostic markers 63 #q#.# [001] 63 neoplasms 63 protein tyrosine phosphatase 63 #S rRNA 63 neuroblastomas 63 FGFs 63 EGFR mutations 63 WT1 63 malignant nodules 63 NF kB pathway 63 diagnostic biomarker 63 IgA deficiency 63 BCL#A 63 ADAM# 63 HER2 HER3 63 myeloproliferative disorders 63 Activating mutations 63 cAMP signaling 63 Fibroblast Growth Factor Receptor 63 metalloprotease 63 miR #b [002] 63 NPM1 63 familial pancreatic cancer 63 GSTP1 63 adenoviral 63 extramedullary 63 FLT3 63 gastric adenocarcinoma 63 PALB2 63 gene fusions 63 JAK2 enzyme 63 gastrointestinal stromal tumors GISTs 63 C1q 63 chromosomal aberrations 63 druggable targets 63 T#M 63 pilocytic astrocytomas 63 sarcomatoid 63 chromatin structure 63 germline mutation 63 H#K#me# 63 Tr DNA 63 E#F# 63 conserved sequences 63 C. albicans 63 florbetaben 63 androgen receptor AR 63 MSH2 62 KRAS mutation 62 maternally inherited 62 mRNA transcripts 62 haematopoietic 62 methylation patterns 62 Wwox 62 medulloblastomas 62 genomewide 62 NSCLC tumors 62 transcriptional regulation 62 selective antagonists 62 tRNA synthetase 62 viral proteins 62 heterologous expression 62 PCR assay 62 KRAS oncogene 62 5 hmC 62 dermatophytes 62 deacetylation 62 ADPKD 62 Cathepsin B 62 oncoproteins 62 clade B 62 cDNAs 62 rRNA 62 ribosomal protein 62 adenomatous polyps 62 cyclin E 62 breast carcinomas 62 N Myc 62 hyperplastic 62 operons 62 gastric carcinomas 62 untranslated regions 62 hypermethylation 62 tumoral 62 vimentin 62 osteosarcomas 62 activating mutations 62 genes differentially expressed 62 RNA sequences 62 HDACs 62 pituitary adenomas 62 secretory pathway 62 neoplasm 62 #S rDNA 62 malignant transformation 62 susceptibility loci 62 chromosome #q#.# [002] 62 SOD1 62 CALHM1 62 previously uncharacterized 62 mRNA expression 62 genetic loci 62 Chlamydia pneumoniae 62 TCF#L# gene 62 Wnt signaling pathway 62 Cyclin D1 62 choroidal neovascularization 62 SIRT2 62 phylogenetic analyzes 62 metabolomic profiles 62 SHANK3 62 array CGH 62 urine cytology 62 T#I [002] 62 miRs 62 C. jejuni 62 TTR gene 62 ribosomal DNA 62 microsatellite instability 62 immunohistochemical 62 Aurora kinase 62 metaplasia 62 pheochromocytoma 62 TSLP 62 p# activation 62 VIPR2 62 miRNAs miR 62 sortilin 62 transcriptomic 62 TAp# 62 ERK signaling 62 Histological examination 62 gene deletions 62 thyroglobulin 62 aberrant methylation 62 pre malignant lesions 62 Cyclin E 62 LJ# [002] 62 malignant polyps 62 MYCN amplification 62 JAK inhibitors 62 multiplex assay 62 hypermethylated 62 CDH1 62 transferrin receptor 62 Genotypes 62 HCV replication 62 MLL gene 62 TCF#L# 62 BRAF mutation 62 IGFBP2 62 transmembrane proteins 62 replicon 62 COL#A# 62 heterodimers 62 neuroblastoma tumors 62 Six3 62 PCa 62 noncoding RNAs 61 chromosome #q# [002] 61 PPARg 61 endometrioid 61 proteomic analysis 61 distinct subtypes 61 ALK gene 61 Prox1 61 thymidylate synthase TS 61 methylation markers 61 TPMT 61 polycythemia vera PV 61 demyelinating diseases 61 assay detects 61 intracellularly 61 USP# 61 pathogenic mechanisms 61 eIF 4E 61 nodal metastasis 61 MMP9 61 Squamous 61 mosaicism 61 CagA 61 replicase 61 V#F mutation 61 posttranslational modifications 61 cathepsin K 61 NFκB 61 neoplastic 61 NS4A 61 mitochondrial disorders 61 pathogenic mutations 61 ALK inhibitors 61 murine models 61 microRNAs miRNAs 61 gastric carcinoma 61 G6PD deficiency 61 serologic tests 61 PTEN gene 61 CHD7 61 alveolar epithelial cells 61 PBMCs 61 B7 H3 61 beta1 integrin 61 premalignant lesions 61 chromosome #p#.# 61 histologic subtypes 61 motor neuron degeneration 61 C. pneumoniae 61 CIN2 + 61 micrometastases 61 colorectal neoplasms 61 familial ALS 61 CDK4 61 proto oncogene 61 autoantibody 61 thyrotropin 61 vitro assay 61 chemokine receptor 61 uPA 61 homodimer 61 mutant alleles 61 VEGF receptor 61 CD# expression [001] 61 genetic syndromes 61 IgE antibody 61 immunostaining 61 cervical carcinoma 61 mammographically 61 HSV1 61 NF1 61 somatic mutation 61 #q#.# [002] 61 oncogenic mutations 61 bacterial genomes 61 beta amyloid peptides 61 thioredoxin 61 endostatin 61 prostate carcinoma 61 HGPIN 61 UsiRNAs 61 metastatic neuroendocrine tumors 61 thyroid carcinoma 61 splice junctions 61 HER2 receptor 61 MMP# 61 small molecule activators 61 chromosomal regions 61 MECP2 gene 61 seminomas 61 invasive carcinoma 61 granzyme B 61 Cytochrome P# 61 effector function 61 pRb 61 MDR1 61 Cytogenetic 61 neuroendocrine carcinoma 61 cell lysates 61 breast carcinoma 61 kDa protein 61 viral nucleic acid 61 nAChRs 61 atherosclerotic lesions 61 herpesviruses 61 cell adhesion molecule 61 histone deacetylase HDAC 61 dimeric 61 ABCB1 61 viral genomes 61 lung adenocarcinoma 61 Upregulation 61 nAChR 61 microRNA molecules 61 cyclophilin D 61 susceptibility gene 61 OGG1 61 Gleevec resistant 61 TNFa 61 Polymerase 61 coding sequences 61 trophoblast cells 61 cerebrospinal fluid CSF 61 HAAH 61 biologic pathway 61 TGF ß 61 hematopoietic cells 61 Epidermal Growth Factor Receptor 61 lymphocytic 61 gastric cancers 61 PI3K Akt 61 HG PIN 61 KCNH2 61 ribosomal RNA rRNA 61 HER2 overexpression 61 causative mutations 61 S. aureus isolates 61 immunohistochemical analysis 61 paragangliomas 61 NRTI resistance 61 FGFR4 61 hydrolase 61 transfected cells 61 peptidic 61 Epstein Barr virus EBV 61 proteinase 61 TMEM#B 61 pulmonary metastases 61 UGT#A# 61 plastid 61 CYP#D# gene 61 PTEN mutations 61 TNF α 61 unmethylated 61 BMP4 60 phosphate S1P 60 de novo mutations 60 ORMDL3 60 penetrance 60 genetic variants associated 60 urothelial carcinoma 60 histone acetylation 60 ABL1 60 hepatoma 60 Transcriptome 60 genomic rearrangements 60 grade cervical intraepithelial 60 MC1R gene 60 immunoregulation 60 genetic aberrations 60 MTHFR gene 60 SNP rs# [001] 60 apoptotic pathway 60 adenomatous 60 NF1 gene 60 Leydig cell 60 basal cell carcinomas 60 meningiomas 60 Alu elements 60 ESBLs 60 histone modification 60 MTHFR 60 transmembrane receptor 60 soluble proteins 60 mammary cells 60 integral membrane proteins 60 histologically 60 ESBA# 60 IDH1 mutation 60 viral isolates 60 paralogs 60 Immunohistochemical staining 60 enzymatic activity 60 plasma kallikrein 60 HER2 positive cancers 60 EGFR protein 60 cathepsins 60 prion strains 60 cytotoxin 60 advanced adenomas 60 SERMs 60 micro RNAs 60 MicroRNA 60 PI3K inhibitors 60 acinar cells 60 MLH1 60 cytopathic 60 fluoroquinolone resistance 60 CYP#B# 60 transcriptional repressor 60 evolutionarily conserved 60 transmembrane protein 60 mutant allele 60 EphA2 60 renal carcinoma 60 variant allele 60 uveal melanoma 60 quasispecies 60 HPV# 60 microRNA miR 60 C5aR 60 perivascular 60 alpha7 60 astrocytomas 60 Histologically 60 chromosome #q#.# [001] 60 lung carcinomas 60 VE cadherin 60 palladin 60 tumor antigen 60 leiomyomas 60 site directed mutagenesis 60 biomarker identification 60 trophoblasts 60 kinase gene 60 BRAF protein 60 SCN5A 60 oligonucleotide microarray 60 colon tumors 60 SMAD4 60 rs# [001] 60 prostate epithelial cells 60 multiprotein complex 60 proteoglycan 60 biochemical assays 60 nucleic acid sequence 60 multigenic 60 oncoprotein 60 FMR1 gene 60 oxysterols 60 TMPRSS2 ERG 60 Plasmodium vivax 60 circulating endothelial cells 60 pDCs 60 ERK pathway 60 #p#.# [002] 60 Enterobacter 60 C#Y 60 IL 1β 60 HFE gene 60 microdeletion 60 cutaneous lesions 60 membrane fusion 60 receptor gene 60 5 methylcytosine 60 BRAF mutations 60 nucleoside analogues 60 genomic variants 60 microarray experiments 60 hepatocellular carcinomas 60 nucleotide substitutions 60 antisense RNA 60 RQ PCR 60 S. maltophilia 60 ELISpot 60 Fig. 1D 60 airway hyperresponsiveness 60 melatonin receptor 60 TOP2A 60 receptor tyrosine kinase inhibitor 60 myeloid 60 CXCR7 60 MLL2 60 Xanafide 60 IgG1 60 GBM tumors 60 γ secretase 60 Lyn kinase 60 epithelial tissues 60 chromosomal anomalies 60 cellular prion protein 60 unmethylated DNA 60 epithelial cancers 60 mitogen activated protein kinase 60 annexin V 60 K#R [002] 60 neuropilin 60 homologous genes 60 MRSA isolates 60 Fas ligand 60 ENMD # 60 RRM1 60 H pylori 60 IFN gamma 60 CCR3 60 malignant lesions 60 P. gingivalis 60 invasive carcinomas 60 cardiac troponin T 60 cisplatin resistant 60 Mycoplasma pneumoniae 60 Francisella 60 immunoglobulin genes 60 FUS1 60 Helicobacter 60 HLA DR 60 CYT# potent vascular disrupting 60 missense mutation 60 kinase inhibition 60 BCR ABL 60 bladder cancers 60 E3 ligase 60 bronchial epithelial cells 60 GPC5 60 ribosomal proteins 60 occludin 60 TGFBR1 * 6A 60 VHL gene 60 potent inhibitors 60 C. neoformans 60 histocompatibility 60 genomic deletions 60 Leukemias 60 Flt3 60 endometrial cancers 60 multiplex PCR 60 colorectal polyp 60 redox active 60 EGFR inhibitors 60 AT1R 60 GPR# [002] 60 endogenous retroviruses 60 anti angiogenic drugs 60 sphingolipid 60 molecular subtypes 60 activating mutation 60 GIST tumors 60 Neisseria gonorrhoeae 60 biochemical abnormalities 60 collagens 60 mitochondrial DNA mtDNA 60 histone deacetylases 60 HPV genotypes 60 WDR# 60 opportunistic pathogens 60 serotonin receptor 60 interferon γ 60 CD#b 60 Epstein Barr Virus EBV 60 immunocompetent 60 antisense inhibitors 60 intergenic regions 60 BARD1 60 immunochemical 60 myeloma cells 60 phosphoprotein 60 Hurthle cell 60 genome rearrangements 60 multidrug resistance 60 NS5A 60 BMP signaling 60 Shh signaling 60 selective inhibition 60 RUNX3 60 IgG antibodies 60 vestibular schwannomas 60 peptide antigens 60 lung metastasis 60 ERalpha 60 pathologic examination 60 KRAS mutations 60 nucleotide sequence 60 KIF6 gene 60 infectious prion proteins 60 detecting colorectal cancer 60 mitochondrial dysfunction 60 promoter hypermethylation 60 MALAT1 60 Nanobacteria 60 TIMP 60 mesothelial cells 60 malignant phenotype 60 CHEK2 60 scintigraphic 60 lobular 60 HLA B# 60 haemolytic 60 sPLA2 59 tumor suppressor protein 59 gene inactivation 59 lobular carcinomas 59 #q# [001] 59 FISH fluorescence 59 VNTR 59 colonic polyps 59 mTOR inhibitors 59 KRAS BRAF 59 Genetic variants 59 CYP#C# [002] 59 isoenzyme 59 #S rRNA gene 59 histopathologic examination 59 GABAB receptors 59 allelic variants 59 NADPH oxidase 59 node metastases 59 GBA mutations 59 malignant prostate 59 biologic pathways 59 β1 59 pleomorphic 59 neuroendocrine cancers 59 CNTNAP2 59 ncRNAs 59 MC4R gene 59 mutant enzymes 59 fluconazole resistant 59 modifier genes 59 demyelinating 59 IDH1 59 oligonucleotide probes 59 differential gene expression 59 Salmonella serotypes 59 previously undescribed 59 Immunoassays 59 Monoclonal 59 microglial activation 59 clusterin 59 isotype 59 Gliomas 59 chromosome #q# [001] 59 hepatocellular carcinoma HCC 59 basal cell carcinoma BCC 59 lymphoid cells 59 neoplastic cells 59 neoplasia 59 antisense oligonucleotides 59 STAT4 59 chlamydial infection 59 JAK2 59 BCR ABL mutations 59 constitutively expressed 59 Supplementary Fig 59 IRS1 59 viral nucleic acids 59 HepG2 cells 59 PDE#A 59 costimulatory 59 phenotypic variation 59 mesotheliomas 59 FOXP3 59 lymphoma subtypes 59 mRNA molecules 59 HRCT 59 ductal lobular 59 BMPR2 59 Leydig cells 59 DNA intercalator 59 ovarian carcinoma 59 eosinophilic 59 EBV infection 59 osteoclast 59 HER2 amplification 59 EGF receptor 59 molecular determinants 59 multiplex ligation dependent 59 IGFBP 3 59 GRP# 59 COX2 59 C. trachomatis 59 EphB4 59 Kv#.# 59 GNAQ 59 immunofluorescence staining 59 BCR ABL1 59 A. fumigatus 59 RKIP 59 nucleotide sequences 59 morphologic 59 mammary cancers 59 microarray gene expression 59 intronic 59 piRNAs 59 VEGFR1 59 TSC1 59 chromosomal translocations 59 phagocytic cells 59 myelomas 59 outer membrane proteins 59 mammary stem cells 59 genetic heterogeneity 59 MHC molecules 59 malignancies 59 intracellular bacteria 59 Trichophyton rubrum 59 PDGFR 59 Plasmodium falciparum 59 adipogenic 59 indels 59 lymphoblastoid cell lines 59 Nucleic acids 59 cytotoxic therapies 59 retroviral infection 59 K ras 59 mitochondrial metabolism 59 leiomyoma 59 aCGH 59 somatostatin receptors 59 HLA DRB1 59 RNase L 59 tumor specific antigen 59 messenger RNAs mRNAs 59 NR#A# 59 glioma cells 59 coexpression 59 beta2 adrenergic receptor 59 EoE 59 biomarker assay 59 colorectal tumors 59 Pseudomonas aeruginosa infections 59 Sjögren syndrome 59 liver metastasis 59 Haptoglobin 59 Polymorphisms 59 nucleolin 59 MALT lymphoma 59 bone scintigraphy 59 amyloid deposition 59 anti CD# antibodies 59 GLUT1 59 CXCR4 59 CYP#E# 59 cDNA libraries 59 cellular pathways 59 secreted protein 59 HOX genes 59 LKB1 59 osteoblastic 59 progranulin gene 59 myeloperoxidase 59 carcinoembryonic antigen 59 prostate carcinomas 59 homologs 59 PTEN protein 59 basal cell nevus syndrome 59 CCL# 59 monocytic 59 histopathologic 59 phosphatases 59 receptor molecule 59 imatinib resistance 59 Estrogen Receptor 59 sputum specimens 59 MMP inhibitors 59 #p#.# [001] 59 cervical intraepithelial neoplasia 59 tumor hypoxia 59 MIF protein 59 PI3K AKT 59 micronuclei 59 FGFR 59 tRNA synthetases 59 IGF IR 59 papillary RCC 59 chromosome #q 59 TET2 59 neuroendocrine tumors 59 metazoan 59 malignant growths 59 PKCi 59 gene BRCA2 59 receptor ligand 59 lymph node metastases 59 pathophysiologic mechanism 59 Notch1 59 atypical hyperplasia 59 LPA gene 59 neuroligins 59 invasive ductal 59 MEK inhibitors 59 DNA methyltransferases 59 autosomal 59 CYP#D# 59 NKX#.# 59 epigenetic alterations 59 gene loci 59 micro RNA 59 EGFR blockers 59 human leukocyte antigen 59 adducts 59 D#N 59 autism susceptibility genes 59 mediated inhibition 59 intestinal epithelial cells 59 urothelial bladder cancer 59 TRPV3 59 parainfluenza virus 59 TP# mutations 59 splice variant 59 Aspergillus species 59 DEAR1 59 EGFR gene 59 podocytes 59 putative biomarkers 59 CFTR gene 59 antisense compounds 59 leukaemias 59 p# MAPK 59 essential thrombocythemia 59 miRNAs 59 S#A# [002] 59 metachronous 59 murine model 59 HMGA2 59 5 hydroxymethylcytosine 59 CEACAM1 59 microcephalin 59 Prion diseases 59 G Protein Coupled 59 CYP #A# 59 autoantibodies 59 Galectin 59 CD#c 59 SOCS3 59 immunized mice 59 miR #a [002] 59 genetic polymorphisms 59 H#K# [001] 59 diagnostic biomarkers 59 ChIP chip 59 photoactivation 59 adrenocortical cancer 59 intercellular signaling 59 adenylate cyclase 59 Hedgehog signaling 59 cell adhesion molecules 59 etiological 59 shRNAs 59 hematopoietic progenitor cells 59 tumor biopsies 59 ductal cancer 59 CXCR4 receptor 59 SPINK1 59 costimulation 59 transgenic mouse models 59 murine leukemia virus 59 APOE e4 59 autoantigens 59 CNVs 59 colorectal carcinogenesis 59 CpG 59 papillary renal cell carcinoma 59 sDNA 59 penile cancers 59 chromosome #p# [001] 59 ccRCC 59 miR #a [001] 59 etiologic 59 schwannomas 59 neoplastic lesions 59 EGFR HER2 59 papillary 59 premalignant 59 eotaxin 59 leukemias lymphomas 59 glycan 59 gastrointestinal stromal tumors 59 nonsmall cell lung cancer 59 estrogen receptor beta 59 genomic loci 59 TIMP 1 59 ImmuKnow 59 endoglin 59 karyotype 59 colorectal cancer CRC 59 somatostatin 59 indel 59 interferon IFN 59 prostate cancer CaP 59 sequenced genomes 59 bile acid metabolism 59 rifamycins 59 CYP# [001] 59 mutations 59 BRAF V#E mutation 59 PKC inhibitors 59 CYP# [002] 59 homodimers 59 epigenetic mechanisms 59 epithelial barrier 59 serologic 59 histologies 59 homozygosity 59 #p# [001] 59 pDC 59 parthenolide 59 PC# cells 59 genes encode proteins 59 Fibroblast 59 IDH mutations 59 apoE 59 presymptomatic 59 CCR9 58 calculi 58 S. cerevisiae 58 LIS1 58 ataxias 58 carcinoid tumors 58 flavopiridol 58 Trichomonas vaginalis 58 microbiomes 58 p#/CBP 58 chemoresistant 58 nucleases 58 telomerase inhibitor 58 PAX5

Back to home page